Clinical trial
Bleeding Pattern Study
NCT00302666 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00302666 |
|---|---|
| Title | Bleeding Pattern Study |
| Official title | Comparative, Prospective, Multi-Center, Open, Randomized Study to Investigate Bleeding Patterns, Metabolic Effects, Contraceptive Efficacy, Acceptance, and Safety of an Oral Contraceptive Containing 0.03 mg Ethinylestradiol and 2 mg Dienogest, in Two Different Regimens of Intake (Four Extended… |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Oral Contraceptive |
| Intervention type | Drug |
| Interventions | Valette (Dienogest/EE30, BAY86-5038) |
| Enrollment | 1,315 |
| Start date | Jun 1, 2003 |
| Completion | Feb 1, 2005 |
| First posted | Mar 14, 2006 |
| Last update posted | May 18, 2009 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: